Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parkinson Disease | 56 | 2022 | 710 | 6.320 |
Why?
|
Depressive Disorder | 12 | 2017 | 557 | 2.160 |
Why?
|
Anxiety Disorders | 10 | 2017 | 678 | 1.560 |
Why?
|
Cognition Disorders | 9 | 2022 | 786 | 1.430 |
Why?
|
Psychiatric Status Rating Scales | 15 | 2018 | 899 | 1.050 |
Why?
|
Depression | 18 | 2020 | 1715 | 1.000 |
Why?
|
Anxiety | 13 | 2019 | 1189 | 0.940 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2021 | 8 | 0.830 |
Why?
|
Mental Disorders | 6 | 2016 | 867 | 0.820 |
Why?
|
Stress Disorders, Post-Traumatic | 4 | 2021 | 603 | 0.740 |
Why?
|
Neurodegenerative Diseases | 2 | 2022 | 266 | 0.710 |
Why?
|
Dementia | 4 | 2014 | 454 | 0.680 |
Why?
|
Sleep Wake Disorders | 1 | 2021 | 350 | 0.630 |
Why?
|
Cognitive Dysfunction | 1 | 2022 | 332 | 0.580 |
Why?
|
Dystonia | 2 | 2020 | 163 | 0.560 |
Why?
|
Psychotic Disorders | 4 | 2019 | 150 | 0.540 |
Why?
|
Panic Disorder | 2 | 2011 | 46 | 0.460 |
Why?
|
Depressive Disorder, Major | 3 | 2020 | 431 | 0.460 |
Why?
|
Torticollis | 3 | 2021 | 73 | 0.450 |
Why?
|
Delusions | 2 | 2012 | 20 | 0.440 |
Why?
|
Comorbidity | 11 | 2020 | 2394 | 0.440 |
Why?
|
Veterans | 5 | 2020 | 1654 | 0.440 |
Why?
|
Hallucinations | 2 | 2012 | 35 | 0.430 |
Why?
|
Illusions | 1 | 2012 | 10 | 0.420 |
Why?
|
Health Services | 1 | 2012 | 109 | 0.410 |
Why?
|
Surveys and Questionnaires | 11 | 2018 | 5714 | 0.410 |
Why?
|
Drug Utilization | 1 | 2013 | 180 | 0.410 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 350 | 0.400 |
Why?
|
Disclosure | 1 | 2013 | 181 | 0.400 |
Why?
|
Nootropic Agents | 2 | 2009 | 33 | 0.390 |
Why?
|
Family Health | 3 | 2011 | 326 | 0.390 |
Why?
|
Health Status | 2 | 2012 | 604 | 0.380 |
Why?
|
Disruptive, Impulse Control, and Conduct Disorders | 1 | 2010 | 33 | 0.380 |
Why?
|
Antiparkinson Agents | 2 | 2009 | 72 | 0.350 |
Why?
|
Propylamines | 1 | 2009 | 12 | 0.340 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2009 | 32 | 0.340 |
Why?
|
Dystonic Disorders | 2 | 2021 | 81 | 0.320 |
Why?
|
Ubiquitin-Protein Ligases | 5 | 2014 | 855 | 0.310 |
Why?
|
Prevalence | 11 | 2020 | 3271 | 0.300 |
Why?
|
Humans | 73 | 2022 | 262210 | 0.290 |
Why?
|
Cholinesterase Inhibitors | 2 | 2006 | 112 | 0.280 |
Why?
|
Aged | 36 | 2020 | 70322 | 0.280 |
Why?
|
Middle Aged | 40 | 2020 | 86445 | 0.280 |
Why?
|
Physical Therapy Modalities | 1 | 2006 | 96 | 0.270 |
Why?
|
Male | 46 | 2020 | 123277 | 0.260 |
Why?
|
Severity of Illness Index | 13 | 2018 | 4348 | 0.250 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 4 | 2020 | 231 | 0.250 |
Why?
|
Psychometrics | 6 | 2013 | 947 | 0.250 |
Why?
|
Alcohol Amnestic Disorder | 1 | 2003 | 2 | 0.240 |
Why?
|
Patient Health Questionnaire | 2 | 2020 | 21 | 0.230 |
Why?
|
Indans | 1 | 2004 | 69 | 0.230 |
Why?
|
Mental Health Services | 3 | 2015 | 223 | 0.230 |
Why?
|
United States Department of Veterans Affairs | 3 | 2016 | 611 | 0.220 |
Why?
|
HIV Infections | 1 | 2015 | 2131 | 0.210 |
Why?
|
Female | 43 | 2020 | 142240 | 0.210 |
Why?
|
Cross-Sectional Studies | 11 | 2020 | 4330 | 0.210 |
Why?
|
Alzheimer Disease | 4 | 2015 | 854 | 0.200 |
Why?
|
Aged, 80 and over | 17 | 2020 | 29997 | 0.200 |
Why?
|
Neuropsychological Tests | 7 | 2013 | 1174 | 0.190 |
Why?
|
Parasomnias | 1 | 2019 | 4 | 0.180 |
Why?
|
Unconsciousness | 1 | 2019 | 21 | 0.180 |
Why?
|
Combat Disorders | 1 | 2019 | 22 | 0.180 |
Why?
|
Dreams | 1 | 2019 | 28 | 0.170 |
Why?
|
Tremor | 1 | 2020 | 127 | 0.170 |
Why?
|
Internationality | 1 | 2020 | 208 | 0.170 |
Why?
|
Psychotropic Drugs | 2 | 2011 | 132 | 0.170 |
Why?
|
Sleep | 1 | 2021 | 414 | 0.160 |
Why?
|
Evaluation Studies as Topic | 2 | 2008 | 418 | 0.160 |
Why?
|
Piperidines | 1 | 2004 | 1051 | 0.160 |
Why?
|
Activities of Daily Living | 3 | 2015 | 560 | 0.160 |
Why?
|
Interview, Psychological | 1 | 2018 | 98 | 0.160 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2019 | 134 | 0.150 |
Why?
|
Hippocampus | 1 | 2003 | 919 | 0.150 |
Why?
|
Brain Concussion | 1 | 2019 | 194 | 0.150 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 165 | 0.140 |
Why?
|
Public Housing | 1 | 2016 | 14 | 0.140 |
Why?
|
Substance-Related Disorders | 2 | 2018 | 529 | 0.140 |
Why?
|
Practice Patterns, Physicians' | 3 | 2015 | 1303 | 0.130 |
Why?
|
Adult | 22 | 2021 | 78087 | 0.130 |
Why?
|
Suicidal Ideation | 1 | 2018 | 207 | 0.130 |
Why?
|
Age of Onset | 6 | 2014 | 826 | 0.130 |
Why?
|
Apathy | 1 | 2015 | 18 | 0.130 |
Why?
|
Psychiatry | 1 | 2019 | 299 | 0.130 |
Why?
|
Phenotype | 3 | 2021 | 6273 | 0.130 |
Why?
|
Brain Injuries, Traumatic | 1 | 2020 | 367 | 0.130 |
Why?
|
Elective Surgical Procedures | 1 | 2016 | 255 | 0.130 |
Why?
|
Pilot Projects | 4 | 2015 | 2801 | 0.120 |
Why?
|
Motor Skills Disorders | 2 | 2014 | 20 | 0.120 |
Why?
|
Fatigue | 3 | 2010 | 1239 | 0.120 |
Why?
|
Disabled Persons | 1 | 2015 | 124 | 0.120 |
Why?
|
Heterozygote | 3 | 2014 | 1018 | 0.110 |
Why?
|
Cooperative Behavior | 1 | 2015 | 314 | 0.110 |
Why?
|
Role | 1 | 2013 | 48 | 0.110 |
Why?
|
Mental Health | 2 | 2014 | 409 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 3 | 2010 | 5541 | 0.110 |
Why?
|
Patient Readmission | 1 | 2016 | 552 | 0.110 |
Why?
|
Convergence, Ocular | 1 | 2011 | 5 | 0.100 |
Why?
|
ROC Curve | 2 | 2020 | 1180 | 0.100 |
Why?
|
Patient-Centered Care | 1 | 2015 | 298 | 0.100 |
Why?
|
Mass Screening | 1 | 2020 | 1505 | 0.100 |
Why?
|
Dopamine Agents | 1 | 2011 | 38 | 0.100 |
Why?
|
Schizophrenia | 1 | 2015 | 372 | 0.100 |
Why?
|
Analysis of Variance | 4 | 2016 | 2311 | 0.100 |
Why?
|
Independent Living | 1 | 2012 | 73 | 0.100 |
Why?
|
Early Diagnosis | 1 | 2013 | 301 | 0.100 |
Why?
|
Ocular Motility Disorders | 1 | 2011 | 47 | 0.100 |
Why?
|
Odds Ratio | 3 | 2011 | 2326 | 0.100 |
Why?
|
Memory Disorders | 2 | 2004 | 295 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2013 | 323 | 0.100 |
Why?
|
Behavior Therapy | 1 | 2013 | 295 | 0.100 |
Why?
|
Movement | 1 | 2014 | 557 | 0.090 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2010 | 31 | 0.090 |
Why?
|
Oculomotor Muscles | 1 | 2011 | 179 | 0.090 |
Why?
|
Database Management Systems | 1 | 2010 | 63 | 0.090 |
Why?
|
Glucosylceramidase | 1 | 2010 | 22 | 0.090 |
Why?
|
Databases as Topic | 1 | 2010 | 134 | 0.090 |
Why?
|
Societies, Scientific | 1 | 2010 | 75 | 0.090 |
Why?
|
alpha-Synuclein | 3 | 2005 | 118 | 0.090 |
Why?
|
Research Design | 2 | 2015 | 1562 | 0.090 |
Why?
|
Comparative Effectiveness Research | 1 | 2010 | 130 | 0.090 |
Why?
|
Point Mutation | 2 | 2010 | 769 | 0.090 |
Why?
|
Atomoxetine Hydrochloride | 1 | 2009 | 16 | 0.090 |
Why?
|
Primary Health Care | 1 | 2015 | 790 | 0.080 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 1155 | 0.080 |
Why?
|
Neoplasms | 1 | 2015 | 15204 | 0.080 |
Why?
|
Nerve Tissue Proteins | 3 | 2005 | 1492 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 928 | 0.080 |
Why?
|
Brief Psychiatric Rating Scale | 1 | 2008 | 9 | 0.080 |
Why?
|
Psychological Tests | 1 | 2009 | 131 | 0.080 |
Why?
|
Substantia Nigra | 1 | 2008 | 41 | 0.080 |
Why?
|
Genetic Counseling | 1 | 2010 | 380 | 0.080 |
Why?
|
Lewy Body Disease | 2 | 2004 | 20 | 0.080 |
Why?
|
Health Planning Guidelines | 1 | 2008 | 58 | 0.080 |
Why?
|
United States | 6 | 2019 | 15561 | 0.080 |
Why?
|
Guidelines as Topic | 1 | 2010 | 384 | 0.080 |
Why?
|
Delivery of Health Care | 1 | 2015 | 868 | 0.080 |
Why?
|
Movement Disorders | 1 | 2010 | 232 | 0.070 |
Why?
|
Prefrontal Cortex | 1 | 2009 | 230 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 3752 | 0.070 |
Why?
|
Education | 1 | 2007 | 112 | 0.070 |
Why?
|
Models, Statistical | 1 | 2013 | 1177 | 0.070 |
Why?
|
Caregivers | 1 | 2013 | 680 | 0.070 |
Why?
|
Deep Brain Stimulation | 1 | 2011 | 351 | 0.070 |
Why?
|
Adrenergic Agonists | 1 | 2006 | 14 | 0.070 |
Why?
|
MEDLINE | 1 | 2006 | 37 | 0.070 |
Why?
|
Stroke | 1 | 2014 | 1155 | 0.070 |
Why?
|
Mutation | 4 | 2010 | 15194 | 0.070 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2006 | 151 | 0.070 |
Why?
|
Motivation | 1 | 2008 | 500 | 0.070 |
Why?
|
Bipolar Disorder | 1 | 2009 | 374 | 0.060 |
Why?
|
Quality of Life | 5 | 2021 | 4577 | 0.060 |
Why?
|
Plaque, Amyloid | 1 | 2004 | 64 | 0.060 |
Why?
|
Emotions | 1 | 2008 | 567 | 0.060 |
Why?
|
Mammillary Bodies | 1 | 2003 | 3 | 0.060 |
Why?
|
Diencephalon | 1 | 2003 | 14 | 0.060 |
Why?
|
Neuroprotective Agents | 1 | 2006 | 215 | 0.060 |
Why?
|
Databases, Factual | 3 | 2020 | 2234 | 0.060 |
Why?
|
Gastrointestinal Diseases | 1 | 2009 | 587 | 0.060 |
Why?
|
Cohort Studies | 4 | 2020 | 9293 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 2323 | 0.060 |
Why?
|
Consensus | 1 | 2007 | 998 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2007 | 4756 | 0.050 |
Why?
|
Ubiquitin | 1 | 2004 | 345 | 0.050 |
Why?
|
Young Adult | 5 | 2020 | 21474 | 0.050 |
Why?
|
Reference Values | 1 | 2003 | 1098 | 0.050 |
Why?
|
Cerebellar Diseases | 1 | 2002 | 89 | 0.050 |
Why?
|
Risk | 2 | 2020 | 1972 | 0.050 |
Why?
|
Huntington Disease | 1 | 2002 | 135 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2016 | 5565 | 0.050 |
Why?
|
Genetic Testing | 4 | 2010 | 1587 | 0.050 |
Why?
|
Synucleins | 3 | 2005 | 13 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2016 | 32987 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2004 | 624 | 0.050 |
Why?
|
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 2 | 2010 | 21 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2004 | 647 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2013 | 6036 | 0.050 |
Why?
|
Neurons | 2 | 2008 | 2289 | 0.040 |
Why?
|
Iraq War, 2003-2011 | 1 | 2019 | 105 | 0.040 |
Why?
|
Afghan Campaign 2001- | 1 | 2019 | 110 | 0.040 |
Why?
|
Aging | 1 | 2008 | 1538 | 0.040 |
Why?
|
International Cooperation | 2 | 2011 | 323 | 0.040 |
Why?
|
Community Mental Health Services | 1 | 2019 | 37 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2005 | 1265 | 0.040 |
Why?
|
Age Factors | 3 | 2018 | 5386 | 0.040 |
Why?
|
Statistics, Nonparametric | 2 | 2011 | 980 | 0.040 |
Why?
|
Interviews as Topic | 1 | 2020 | 500 | 0.040 |
Why?
|
Genotype | 3 | 2010 | 4107 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2004 | 2598 | 0.040 |
Why?
|
Gene Frequency | 2 | 2010 | 1164 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2018 | 279 | 0.040 |
Why?
|
Cognition | 2 | 2015 | 975 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2021 | 1032 | 0.040 |
Why?
|
Risk Factors | 4 | 2015 | 17605 | 0.040 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2010 | 557 | 0.040 |
Why?
|
Probability | 1 | 2018 | 868 | 0.030 |
Why?
|
Adolescent | 4 | 2020 | 31257 | 0.030 |
Why?
|
Nurses | 1 | 2015 | 82 | 0.030 |
Why?
|
Telephone | 1 | 2015 | 163 | 0.030 |
Why?
|
Disability Evaluation | 1 | 2015 | 256 | 0.030 |
Why?
|
Touch | 1 | 2014 | 71 | 0.030 |
Why?
|
Self Report | 1 | 2018 | 766 | 0.030 |
Why?
|
Electromyography | 1 | 2014 | 227 | 0.030 |
Why?
|
Posture | 1 | 2014 | 215 | 0.030 |
Why?
|
Functional Laterality | 1 | 2014 | 315 | 0.030 |
Why?
|
Program Evaluation | 1 | 2015 | 602 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2012 | 31 | 0.030 |
Why?
|
Models, Neurological | 1 | 2013 | 225 | 0.030 |
Why?
|
Carbidopa | 1 | 2011 | 17 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2020 | 4977 | 0.030 |
Why?
|
Sensation | 1 | 2011 | 71 | 0.020 |
Why?
|
Levodopa | 1 | 2011 | 92 | 0.020 |
Why?
|
Jews | 1 | 2010 | 58 | 0.020 |
Why?
|
Disease Progression | 2 | 2014 | 6695 | 0.020 |
Why?
|
Syndrome | 1 | 2013 | 1352 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2020 | 6105 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2015 | 1949 | 0.020 |
Why?
|
Visual Perception | 1 | 2010 | 154 | 0.020 |
Why?
|
Length of Stay | 1 | 2016 | 1929 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2015 | 2300 | 0.020 |
Why?
|
Executive Function | 1 | 2010 | 159 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2015 | 899 | 0.020 |
Why?
|
Brain | 3 | 2010 | 4113 | 0.020 |
Why?
|
Telemedicine | 1 | 2015 | 474 | 0.020 |
Why?
|
Attention | 1 | 2010 | 280 | 0.020 |
Why?
|
Sex Factors | 1 | 2014 | 2156 | 0.020 |
Why?
|
Pain | 1 | 2017 | 1675 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2009 | 756 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2009 | 277 | 0.020 |
Why?
|
National Institute of Mental Health (U.S.) | 1 | 2007 | 14 | 0.020 |
Why?
|
Decision Making | 1 | 2015 | 1294 | 0.020 |
Why?
|
Hospitals | 1 | 2011 | 490 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2003 | 7727 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 2008 | 172 | 0.020 |
Why?
|
Memory | 1 | 2010 | 429 | 0.020 |
Why?
|
Visual Acuity | 1 | 2011 | 873 | 0.020 |
Why?
|
Regression Analysis | 1 | 2010 | 1550 | 0.020 |
Why?
|
Physicians | 1 | 2015 | 883 | 0.020 |
Why?
|
Cell Line | 2 | 2005 | 5088 | 0.020 |
Why?
|
Lewy Bodies | 1 | 2004 | 10 | 0.020 |
Why?
|
Formates | 1 | 2004 | 9 | 0.020 |
Why?
|
Publishing | 1 | 2007 | 222 | 0.020 |
Why?
|
Epitope Mapping | 1 | 2005 | 108 | 0.020 |
Why?
|
MPTP Poisoning | 1 | 2004 | 4 | 0.020 |
Why?
|
Nitric Oxide Donors | 1 | 2004 | 51 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2004 | 93 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2010 | 2282 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 315 | 0.010 |
Why?
|
DNA Primers | 1 | 2005 | 1394 | 0.010 |
Why?
|
Catalytic Domain | 1 | 2004 | 305 | 0.010 |
Why?
|
tau Proteins | 1 | 2004 | 215 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 3450 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2005 | 835 | 0.010 |
Why?
|
Registries | 1 | 2010 | 2187 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2005 | 702 | 0.010 |
Why?
|
Exons | 1 | 2005 | 1328 | 0.010 |
Why?
|
Cell Death | 1 | 2004 | 672 | 0.010 |
Why?
|
Genetic Variation | 1 | 2009 | 2087 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 4902 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 5008 | 0.010 |
Why?
|
Personality Disorders | 1 | 2002 | 166 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 8883 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 2935 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2004 | 2917 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 1267 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2010 | 38006 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2005 | 4140 | 0.010 |
Why?
|
Prospective Studies | 1 | 2011 | 12914 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2005 | 5606 | 0.010 |
Why?
|
Animals | 3 | 2007 | 59534 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2004 | 2023 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2004 | 5680 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 7558 | 0.010 |
Why?
|
Mice | 2 | 2005 | 34438 | 0.010 |
Why?
|
Prognosis | 1 | 2009 | 21747 | 0.010 |
Why?
|